Cheniere Energy, Inc. (LNG) is set to release first-quarter results on May 8. The Zacks Consensus Estimate for earnings is $2.81 per share on revenues of $4.5 billion. Let's delve into the factors that are likely to have influenced the liquefied natural gas (LNG) exporter's performance in the March quarter. But it's worth taking a look at Cheniere Energy's previous-quarter performance first. Highlights of Q4 Earnings & Surprise History In the last reported quarter, this Houston, TX-based transporter of supe ...

Core Viewpoint - Gartner reported quarterly earnings of $2.98 per share, exceeding the Zacks Consensus Estimate of $2.72 per share, and showing a year-over-year increase from $2.93 per share [1] - The company has consistently surpassed consensus EPS estimates over the last four quarters [2] Financial Performance - Gartner's revenues for the quarter ended March 2025 were $1.53 billion, matching the Zacks Consensus Estimate and reflecting a year-over-year increase from $1.47 billion [2] - The company has also exceeded consensus revenue estimates in the last four quarters [2] Stock Performance and Outlook - Gartner shares have declined approximately 11.9% since the beginning of the year, compared to a 3.9% decline in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $3.28, with expected revenues of $1.66 billion, and for the current fiscal year, the estimate is $12.18 on revenues of $6.51 billion [7] Industry Context - The Consulting Services industry, to which Gartner belongs, is currently ranked in the top 30% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Gartner's stock performance [5]

Core Viewpoint - Cleveland-Cliffs Inc. (CLF) is expected to report first-quarter 2025 results on May 7, with anticipated challenges due to lower year-over-year steel prices despite cost-cutting measures and increased volumes [1][5][9]. Revenue Estimates - The Zacks Consensus Estimate for CLF's first-quarter consolidated revenues is $4,596.6 million, indicating an 11.6% year-over-year decline [4]. Performance Factors - CLF is likely to face headwinds from weaker steel prices, with benchmark hot-rolled coil (HRC) prices dropping over 40% last year, closing near $700 per short ton from $1,200 per short ton at the beginning of 2024 [5][6]. - The average net selling price per net ton of steel products is estimated at $986, reflecting a 16.1% year-over-year decrease [8]. Cost Management - The company is expected to benefit from reduced steelmaking unit costs, with a sequential decline of approximately $15 per ton in the fourth quarter of 2024 and an anticipated reduction of about $40 per net ton in 2025 compared to 2024 [9]. Volume Growth - CLF is projected to have experienced higher sales volumes in the March quarter, estimated at 4.06 million net tons, suggesting a 3% year-over-year increase, driven by automotive demand and contributions from the Stelco acquisition [10]. Earnings Prediction - The Earnings ESP for CLF is -25.19%, with the consensus estimate indicating a loss of 67 cents for the first quarter, suggesting a low probability of an earnings beat [11][12].

Core Viewpoint - APA Corporation is expected to report first-quarter 2025 results on May 7, with a consensus estimate of 83 cents per share in profit and revenues of $2.2 billion [1] Group 1: Previous Quarter Performance - In the last reported quarter, APA missed the consensus earnings estimate of 97 cents, reporting adjusted earnings of 79 cents per share, while revenues of $2.5 billion exceeded estimates by nearly 10% due to contributions from the Callon Petroleum acquisition and higher production [2] - APA has beaten the Zacks Consensus Estimate in one of the last four quarters and missed in the others [3] Group 2: Estimate Revisions and Projections - The Zacks Consensus Estimate for the first-quarter earnings has been revised upward by 2.5% in the past week, indicating a 6.4% year-over-year improvement, while revenue estimates suggest a 16.3% increase from the previous year [3] Group 3: Production and Growth Factors - APA is projected to achieve strong production gains in the first quarter, with average volumes expected to reach approximately 300,000 barrels of oil equivalent per day (BOE/d), reflecting a 40% year-over-year increase from 214,050 BOE/d, driven by robust well performance and the Callon Petroleum acquisition [4] - Since 2020, APA has restructured its portfolio with over $5 billion in strategic acquisitions and $2.5 billion in divestitures, resulting in more than doubling its unconventional output in the Permian Basin and enhancing its operational efficiency [5] Group 4: Earnings Surprise Potential - The company has a positive Earnings ESP of +4.52% and a Zacks Rank of 3, indicating a likelihood of an earnings beat this season [6]

For the quarter ended March 2025, Vitesse Energy (VTS) reported revenue of $66.17 million, up 8.1% over the same period last year. EPS came in at $0.23, compared to $0.34 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $65.06 million, representing a surprise of +1.71%. The company delivered an EPS surprise of +155.56%, with the consensus EPS estimate being $0.09.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...

分组1 - National Storage (NSA) reported quarterly funds from operations (FFO) of $0.54 per share, missing the Zacks Consensus Estimate of $0.56 per share, and down from $0.60 per share a year ago, representing an FFO surprise of -3.57% [1] - The company posted revenues of $188.35 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.42%, but down from $196.15 million year-over-year [2] - Over the last four quarters, National Storage has surpassed consensus FFO estimates two times and topped consensus revenue estimates two times [2] 分组2 - The stock's immediate price movement will depend on management's commentary on the earnings call and future FFO expectations [3][4] - National Storage shares have lost about 0.5% since the beginning of the year, compared to the S&P 500's decline of -3.3% [3] - The current consensus FFO estimate for the coming quarter is $0.58 on $189.51 million in revenues, and $2.32 on $761.62 million in revenues for the current fiscal year [7] 分组3 - The Zacks Industry Rank for REIT and Equity Trust - Other is currently in the bottom 37% of over 250 Zacks industries, indicating potential challenges for the sector [8] - Empirical research shows a strong correlation between near-term stock movements and trends in estimate revisions, which can impact investor decisions [5][6]

Company Overview - Fox Corporation is expected to report quarterly earnings of $0.96 per share, reflecting a year-over-year decline of 11.9% [3] - Revenues are anticipated to reach $4.15 billion, which is an increase of 20.5% compared to the same quarter last year [3] Earnings Expectations - The consensus EPS estimate has been revised 4.84% higher in the last 30 days, indicating a positive reassessment by analysts [4] - The Most Accurate Estimate for Fox is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +4.53% [10][11] - Fox currently holds a Zacks Rank of 2 (Buy), suggesting a strong likelihood of beating the consensus EPS estimate [11] Historical Performance - In the last reported quarter, Fox exceeded the expected earnings of $0.61 per share by delivering $0.96, resulting in a surprise of +57.38% [12] - Over the past four quarters, Fox has beaten consensus EPS estimates three times [13] Industry Context - E.W. Scripps, another player in the Zacks Broadcast Radio and Television industry, is expected to report a loss of $0.23 per share, indicating a year-over-year change of -130% [17] - E.W. Scripps has an Earnings ESP of 0.00% and has not beaten consensus EPS estimates in any of the last four quarters [18]

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for 3D Systems despite lower revenues, with a focus on how actual results will compare to estimates [1][2] Earnings Expectations - 3D Systems is expected to report a quarterly loss of $0.13 per share, reflecting a year-over-year change of +23.5% [3] - Revenues are projected to be $98.39 million, down 4.4% from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised 3.23% higher in the last 30 days, indicating a positive reassessment by analysts [4] - A positive Earnings ESP of +36% suggests analysts are bullish on the company's earnings prospects [10][11] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [8] - The current Zacks Rank for 3D Systems is 3, indicating a likelihood of beating the consensus EPS estimate [11] Historical Performance - In the last reported quarter, 3D Systems was expected to post a loss of $0.11 per share but actually reported a loss of $0.19, resulting in a surprise of -72.73% [12] - The company has not beaten consensus EPS estimates in any of the last four quarters [13] Conclusion - While 3D Systems appears to be a compelling earnings-beat candidate, other factors should also be considered when evaluating the stock ahead of its earnings release [16]

Core Viewpoint - The market anticipates a year-over-year decline in earnings for Arcturus Therapeutics despite an increase in revenues, with the actual results being crucial for stock price movement [1][2]. Earnings Expectations - Arcturus Therapeutics is expected to report a quarterly loss of $1.13 per share, reflecting a year-over-year change of -13% [3]. - Revenues are projected to be $38.08 million, which is a slight increase of 0.2% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 5% over the last 30 days, indicating a bearish sentiment among analysts [4]. - The Most Accurate Estimate for Arcturus is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -9.49% [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with a strong predictive power for positive readings [6][7]. - Stocks with a positive Earnings ESP and a Zacks Rank of 1, 2, or 3 have historically shown a nearly 70% chance of a positive surprise [8]. Historical Performance - In the last reported quarter, Arcturus was expected to post a loss of $0.34 per share but instead reported a loss of $1.11, resulting in a surprise of -226.47% [12]. - Over the past four quarters, Arcturus has beaten consensus EPS estimates three times [13]. Conclusion - Arcturus Therapeutics does not appear to be a strong candidate for an earnings beat based on current estimates and rankings, suggesting caution for investors [16].

Core Viewpoint - Regenxbio (RGNX) is anticipated to report a significant year-over-year increase in earnings and revenues for the quarter ended March 2025, which could influence its stock price depending on the actual results compared to estimates [1][2]. Earnings Expectations - The upcoming earnings report is expected to be released on May 12, 2025, with a consensus estimate of $0.41 per share, reflecting a year-over-year increase of +129.7% [3]. - Revenues are projected to reach $109.98 million, representing a substantial increase of 604.1% from the same quarter last year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 6.26%, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Regenxbio is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +57.77% [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive Earnings ESP reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [8]. - Regenxbio currently holds a Zacks Rank of 3, indicating a likelihood of beating the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, Regenxbio was expected to post a loss of $1.27 per share but actually reported a loss of $1.01, resulting in a surprise of +20.47% [12]. - Over the past four quarters, the company has surpassed consensus EPS estimates two times [13]. Industry Context - In the Zacks Medical - Biomedical and Genetics industry, Sangamo Therapeutics (SGMO) is expected to report a loss of $0.11 per share for the same quarter, with a year-over-year change of +59.3% [17]. - Sangamo's revenue is projected to be $9.17 million, up 1810.4% from the previous year [17]. - Despite a recent downward revision of 23.8% in consensus EPS estimates, Sangamo has an Earnings ESP of 27.27%, but it holds a Zacks Rank of 4 (Sell), making predictions of an earnings beat uncertain [18].